Department of urology

Justin Ellett, MD, PhD

Justin Ellett, MD



Medical University of South Carolina
Department of Urology
96 Jonathan Lucas Street, CSB644
P.O. Box 250620
Charleston, SC 29425
Facsimile 843-792-8523








Information on Justin Ellett, MD, PhD


Education

1998-2002  - Hampden-Sydney College, BS Summa cum laude, Biology and Mathematics

2003-2011 - Medical University of South Carolina, Doctor of Medicine

2005-2009 - Medical University of South Carolina, - PhD Microbiology and Immunology

July 2011 – Present - Residency, Urology:  Medical University of South Carolina

Awards

1998-2002 Dean’s List and Academic Honors

1998-2002 Allan Merit Full Academic Scholarship

2000 Omicron Delta Kappa Leadership Honor Society – Hampden-Sydney College

2001 Phi Beta Kappa Honor Society – Hampden-Sydney College

2001 Hunter Overcash Award – Hampden-Sydney College

2002 Samuel Jones Phi Beta Kappa Award for Research – Hampden-Sydney College

2008 American Federation for Medical Research Scholar Award

2008 American Federation for Medical Research Outstanding Achievement in Medical Student Research Award

2010 Association for Academic Surgery Student Research Award


Publications

Ellett JD, Rosoff JS, Prasad SM. Long-term differences in urinary, bowel and
sexual function among men treated with surgery versus radiation for prostate
cancer. Asian J Androl. 2013 Jul;15(4):443-4.


Hughes FM Jr, McKeithan P, Ellett J, Armeson KE, Purves JT. Simvastatin
suppresses cyclophosphamide-induced changes in urodynamics and bladder
inflammation. Urology. 2013 Jan;81(1):209.e9-14.


Evans ZP, Palanisamy AP, Sutter AG, Ellett JD, Ramshesh VK, Attaway H, Schmidt
MG, Schnellmann RG, Chavin KD. Mitochondrial uncoupling protein-2 deficiency
protects steatotic mouse hepatocytes from hypoxia/reoxygenation. Am J Physiol
Gastrointest Liver Physiol. 2012 Feb 1;302(3):G336-42.


Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, Schmidt MG, Schnellmann
RG, Chavin KD. Toll-like receptor 4 knockout mice are protected from endothelial
overactivation in the absence of Kupffer cells after total hepatic
ischemia/reperfusion. Liver Transpl. 2011 Sep;17(9):1089-98.


Ellett JD, Atkinson C, Evans ZP, Amani Z, Balish E, Schmidt MG, van Rooijen N,
Schnellmann RG, Chavin KD. Murine Kupffer cells are protective in total hepatic
ischemia/reperfusion injury with bowel congestion through IL-10. J Immunol. 2010
May 15;184(10):5849-58.


Ellett JD, Campbell JA, Gonsalves WC. Patient satisfaction in a student-run
free medical clinic. Fam Med. 2010 Jan;42(1):16-8.


Evans ZP, Mandavilli BS, Ellett JD, Rodwell D, Fariss MW, Fiorini RN,
Schnellmann RG, Schmidt MG, Chavin K. Vitamin E succinate enhances steatotic
liver energy status and prevents oxidative damage following ischemia/reperfusion.
Transplant Proc. 2009 Dec;41(10):4094-8.


He S, Atkinson C, Evans Z, Ellett JD, Southwood M, Elvington A, Chavin KD,
Tomlinson S. A role for complement in the enhanced susceptibility of steatotic
livers to ischemia and reperfusion injury. J Immunol. 2009 Oct 1;183(7):4764-72.

Ellett JD, Evans ZP, Atkinson C, Schmidt MG, Schnellmann RG, Chavin KD.
Toll-like receptor 4 is a key mediator of murine steatotic liver warm
ischemia/reperfusion injury. Liver Transpl. 2009 Sep;15(9):1101-9.


Evans ZP, Ellett JD, Fariss MW, Schnellmann RG, Schmidt MG, Chavin K. Vitamin
E succinate reduces ischemia/reperfusion injury in steatotic livers. Transplant
Proc. 2008 Dec;40(10):3327-9.


Ellett JD, Evans ZP, Zhang G, Chavin KD, Spyropoulos DD. A rapid PCR-based
method for the identification of ob mutant mice. Obesity (Silver Spring). 2009
Feb;17(2):402-4.


Ellett JD, Evans ZP, Fiorini JH, Fiorini RN, Haines JK, Schmidt MG, Chavin
KD. The use of the Papworth cocktail is detrimental to steatotic livers after
ischemia-reperfusion injury. Transplantation. 2008 Jul 27;86(2):286-92.

Evans ZP, Ellett JD, Schmidt MG, Schnellmann RG, Chavin KD. Mitochondrial
uncoupling protein-2 mediates steatotic liver injury following
ischemia/reperfusion. J Biol Chem. 2008 Mar 28;283(13):8573-9.


Ellett JD, Carter JD, Chen M, Smith KM, Fialkow LB, McDuffie MJ, Tung KS,
Nadler JL, Yang Z. Viral IL-10-mediated immune regulation in pancreatic islet
transplantation. Mol Ther. 2005 Aug;12(2):360-8.


Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL. Inflammatory
blockade improves human pancreatic islet function and viability. Am J Transplant.
2005 Mar;5(3):475-83.


Carter JD, Chen M, Ellett JD, Smith KM, Nadler JL, Yang Z. Impact of donor
immune cells in pancreatic islet transplantation. Transplant Proc. 2004
Nov;36(9):2866-8.


Yang Z, Chen M, Carter JD, Ellett JD, Smith KM, Nadler JL. Inflammation
blockade improves pancreatic islet function. Transplant Proc. 2004
Nov;36(9):2864-5.


Yang Z, Chen M, Deng S, Ellett JD, Wu R, Langman L, Carter JD, Fialkow LB,
Markmann J, Nadler JL, Brayman K. Assessment of human pancreatic islets after
long distance transportation. Transplant Proc. 2004 Jun;36(5):1532-3.


Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, Nadler JL.
Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun. 2004
May;22(3):191-200.


Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, Nadler JL. The novel
anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after
islet transplantation. Transplantation. 2004 Jan 15;77(1):55-60.
 

Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. Inhibition of STAT4
activation by lisofylline is associated with the protection of autoimmune
diabetes. Ann N Y Acad Sci. 2003 Nov;1005:409-11.


Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Brinkmann V, Nadler JL, Lynch
KR. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic
mice small star, filled. Clin Immunol. 2003 Apr;107(1):30-5.

Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. The novel
anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose
streptozotocin-treated mice. Pancreas. 2003 May;26(4):e99-104.


Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. Survival of
pancreatic islet xenografts in NOD mice with the theracyte device. Transplant
Proc. 2002 Dec;34(8):3349-50.

Yeung F, Li X, Ellett J, Trapman J, Kao C, Chung LW. Regions of
prostate-specific antigen (PSA) promoter confer androgen-independent expression
of PSA in prostate cancer cells. J Biol Chem. 2000 Dec 29;275(52):40846-55.